HKMPY - Hikma Pharmaceuticals PLC

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 4.93B
Enterprise value 5.92B
Trailing P/E 26.49
Forward P/E 11.31
PEG ratio (5-yr expected) 2.41
Price/sales (ttm)1.98
Price/book (mrq)2.29
Enterprise value/revenue 2.35
Enterprise value/EBITDA 12.10

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 34.68%
S&P500 52-week change 32.74%
52-week high 347.25
52-week low 325.12
50-day moving average 344.80
200-day moving average 337.97

Share statistics

Avg vol (3-month) 3774
Avg vol (10-day) 3130
Shares outstanding 5110.35M
Implied shares outstanding 6N/A
Float 877.02M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.12
Forward annual dividend yield 42.53%
Trailing annual dividend rate 30.56
Trailing annual dividend yield 31.26%
5-year average dividend yield 41.88
Payout ratio 465.79%
Dividend date 314 May 2023
Ex-dividend date 422 Mar 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 7.47%
Operating margin (ttm)23.48%

Management effectiveness

Return on assets (ttm)8.35%
Return on equity (ttm)8.28%

Income statement

Revenue (ttm)2.52B
Revenue per share (ttm)22.47
Quarterly revenue growth (yoy)-2.50%
Gross profit (ttm)1.26B
EBITDA 763M
Net income avi to common (ttm)188M
Diluted EPS (ttm)1.67
Quarterly earnings growth (yoy)-91.30%

Balance sheet

Total cash (mrq)292M
Total cash per share (mrq)2.65
Total debt (mrq)1.28B
Total debt/equity (mrq)59.73
Current ratio (mrq)1.86
Book value per share (mrq)19.39

Cash flow statement

Operating cash flow (ttm)530M
Levered free cash flow (ttm)299.5M